-WuXi Advanced Therapies recibe la aprobación de la FDA para fabricar AMTAGVI™ (lifileucel) de Iovance para el melanoma avanzado
AMTAGVI es la primera y única terapia individualizada de células T que recibe la aprobación de la FDA de EE.UU. para un cáncer de tumor sólido.
NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.
